|
|
Article: SMITHKLINE BEECHAM: Study shows SmithKline Beecham Requip relieves symptoms of restless legs syndrome.
- Article from:
- M2 Presswire
- Article date:
- March 5, 1999
CopyrightCOPYRIGHT 1999 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-5 March 1999-SMITHKLINE BEECHAM: Results of a new study in movement disorders show SmithKline Beecham Requip relieves symptoms of restless legs syndrome (C)1994-99 M2 COMMUNICATIONS LTD
RDATE:020399
-- Requip Shows Potential To Treat RLS With Mild Side Effects
Philadelphia, Pennsylvania -- Requip (ropinirole hydrochloride, SmithKline Beecham) was shown to relieve symptoms of Restless Legs Syndrome (RLS), according to an open-label study published this month in Movement Disorders. The study evaluated both the efficacy and adverse event profile of Requip in patients with both primary and secondary RLS. Requip is a second generation ...